Abstract |
We here replaced the cell-binding domain in Pseudomonas exotoxin A (PE) with HIV-binding portion of CD4V1V2 molecule and constructed a chimeric gene CD4V1V2-PE40, which can be expressed in E. coli. The hybrid protein displays targeting toxicity toward cells infected by HIV and thus represents a promising novel therapeutic agent for the treatment of AIDS.
|
Authors | X Zhao, M Zhang, H Li, S Lu |
Journal | Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae
(Zhongguo Yi Xue Ke Xue Yuan Xue Bao)
Vol. 17
Issue 4
Pg. 248-52
(Aug 1995)
ISSN: 1000-503X [Print] China |
PMID | 8575044
(Publication Type: Journal Article)
|
Chemical References |
- Antiviral Agents
- Bacterial Toxins
- CD4 Antigens
- Exotoxins
- Recombinant Fusion Proteins
- Virulence Factors
- ADP Ribose Transferases
- Pseudomonas aeruginosa exotoxin A
|
Topics |
- ADP Ribose Transferases
- Acquired Immunodeficiency Syndrome
- Antiviral Agents
(pharmacology)
- Bacterial Toxins
(genetics)
- CD4 Antigens
(genetics)
- Cloning, Molecular
- Escherichia coli
(genetics, metabolism)
- Exotoxins
(genetics)
- Gene Expression
- Humans
- Plasmids
- Pseudomonas aeruginosa
- Recombinant Fusion Proteins
(biosynthesis, pharmacology)
- Simian Immunodeficiency Virus
(drug effects)
- Virulence Factors
|